Tuesday, August 25, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
HEALTHCARE & FDAFDA Clears Robotic Blood Draw—Phlebotomy Shortage EasestodayDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Direct Win for Oracle, Pressure on Smaller Defense IT Rivals4 weeks agoWHITE HOUSELabor Dept Eases Disability Hiring Rules—Contractors Save Compliance CoststodayTECHFCC Tightens Submarine Cable Licensing Rules—Tech Giants Face New Compliance Costs, Telecom Carriers Gain Regulatory Clarity4 weeks agoWHITE HOUSELabor Dept Eases Veteran Hiring Rules—Contractors Cut CompliancetodayHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—UnitedHealth, Humana, and Anthem Positioned to Gain from Simplified Metrics4 weeks agoTECHCHIPS Act Transforms Binghamton Into Semiconductor HubyesterdayDEFENSEHouse Passes $1.15 Trillion Defense Bill—Lockheed, Raytheon, and General Dynamics Positioned for Record Spending4 weeks agoTRADE & TARIFFSTrump Administration Targets Iran's Banking System With New SanctionsyesterdayDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Largest Defense IT Overhaul in Years4 weeks agoTECHUtah Governor Signs Quantum Computing Initiative OrderyesterdayDEFENSERocket Lab Wins $266M Space Force Contract—Suborbital Launch Capability Becomes Defense Asset4 weeks agoDEFENSEFAA Engine Inspection Order Lifts MRO Stocks2 days agoHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—Big Insurers Win, Quality Metrics Tighten4 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earnings2 days agoDEFENSERocket Lab Wins $266M Space Force Missile Defense Contract—Suborbital Launch Niche Gets Federal Validation4 weeks agoHEALTHCARE & FDATrump Vaccine Spacing Order Reshapes Pharma Demand2 days agoDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Cloud Incumbents Face Pressure, Oracle Locks in Defense Revenue4 weeks agoTECHD-Wave Wins Canadian Quantum Funding for Annealing2 days agoCRYPTOSEC Settles Coinbase FOIA Suit Over Missing Gensler Texts—Crypto Compliance Pressure Eases, Coinbase Stock Gains Clarity4 weeks agoENERGYEnbridge Wins Federal Permit for Line 5 Tunnel3 days agoHEALTHCARE & FDACMS Stars Redo Lifts Medicare Advantage Insurers—Rating System Overhaul Favors UnitedHealth, Humana, Anthem4 weeks agoENERGYFederal Court Orders Enbridge Line 5 Removal3 days agoDEFENSEPentagon Awards Largest F-35 Spare Parts Contract—Lockheed Locks in Sustainment Revenue4 weeks agoWHITE HOUSEFinCEN Finalizes BOI Exemption for U.S. Persons3 days agoDEFENSEHouse Passes $1.15T Defense Bill—Lockheed, Raytheon, General Dynamics Lock in Revenue4 weeks agoHEALTHCARE & FDAGAO Finds $7.6B Medicare Hospice Overpayment4 days agoMARKETSSEC Explores 23-Hour Stock Trading—Market Makers and Tech Platforms Get New Revenue4 weeks agoENERGYNewsom Passes Diablo Canyon Decision to Successor5 days agoENERGYPHMSA Updates Pipeline Safety Standards—Compliance Costs Hit Operators, Benefit Inspectors4 weeks agoDEFENSERTX Lands Fresh Missile Defense Contract—Stock Undervalued6 days agoSEARCH DEMANDCasgevy List Price: $2.2 Million3 weeks agoTECHCommerce Eases Drone Export Rules—U.S. Makers Win6 days agoSEARCH DEMANDData Center Power Exchange3 weeks agoHEALTHCARE & FDAFDA Reclassifies Cancer Tests—Easier Path for Diagnosticslast weekTRADE & TARIFFSAmazon Gets $600M Tariff Refund—Retailers Lift Guidance on Windfall3 weeks agoHEALTHCARE & FDAFTC Probes Epic Systems Over Health Records Monopolylast weekTECHCommerce Awards $874M in Semiconductor R&D LOIs—Chip Makers Get Federal Backing3 weeks agoDEFENSETrump's $1.5T Defense Push Fuels Colorado Contractor Windfalllast weekHEALTHCARE & FDAFDA Revokes Petroleum-Based Food Dyes—Natural Color Makers Win3 weeks agoENERGYEPA Exempts Calcium Carbonate From Pesticide Tolerance—Farm Input Easeslast weekDEFENSEHouse Passes $95B Iran War Package—Defense Contractors Lock in Revenue3 weeks agoWHITE HOUSETrump Vaccine Spacing Order Reshapes Pharma Demandlast weekWHITE HOUSETrump Blocks Critical Minerals Exports—U.S. Miners Get Protected Market3 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Insurers Face Pressurelast weekHEALTHCARE & FDAHumana Exits MA Markets—600K Members Face Plan Disruption3 weeks agoTRADE & TARIFFSTariff Refunds Flow to Retailers—Earnings Boostlast weekENERGYMichigan Court Vacates Line 5 Permit—Enbridge Faces Shutdown Risk3 weeks agoENERGYArmy Corps Permits Line 5 Tunnel—Michigan Blocks Pathlast weekTRADE & TARIFFSAmazon Pockets $600M Tariff Refund—Retail Rivals Face Margin Squeeze3 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earningslast weekHEALTHCARE & FDAHHS Boosts Hospital Payments by $2 Billion—Acute Care Operators Win3 weeks agoCRYPTOSEC Delays Crypto Rules—Uncertainty Persistslast weekHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Drug Plan Insurers Face Margin Pressure3 weeks agoTRADE & TARIFFSKimberly-Clark Pockets $45M Tariff Refundlast weekHEALTHCARE & FDACMS Raises IRF Payments for 2027—Rehab Hospitals Get Relief3 weeks agoTRADE & TARIFFSTrump Tariffs on Drones Boost U.S. Makerslast weekTRADE & TARIFFSTrump Administration Hits $100B Tariff Refund Milestone3 weeks agoHEALTHCARE & FDASimparica Trio Gets Screwworm EUA—Zoetis Winslast weekDEFENSERising Defense Spending Lifts Northrop Grumman Outlook3 weeks agoDEFENSEBlackSky Lands Multi-Year Satellite Contractlast weekMARKETSFTC Threatens Booking Holdings Over Priceline Practices3 weeks agoTECHFCC Eases Broadband Label Rules—ISPs Win Flexibilitylast weekHEALTHCARE & FDAFTC Sues Hims & Hers Over Privacy and Billing Practices3 weeks agoDEFENSEIonQ Lands $28M U.S. Defense Quantum Contractlast weekHEALTHCARE & FDAFDA Approves Tudriqev for Advanced Melanoma3 weeks agoHEALTHCARE & FDAFDA Clears Screwworm Prevention Drug for U.S. Livestocklast weekTRADE & TARIFFSRetailers Sell Off Tariff Refund Rights for Cash—Windfall Monetized Before Payout2 weeks agoENERGYNRC Approves NAC MAGNASTOR Spent Fuel Storage Casklast weekTECHU.S. Signs $874M Semiconductor Research LOIs—Chip Makers Get Federal Backing2 weeks agoHEALTHCARE & FDAFDA Updates Fresh-Cut Produce Safety Guidancelast weekWHITE HOUSEDHS Tightens H-1B/L-1 Visa Fees—Tech Hiring Costs Rise for Employers2 weeks agoWHITE HOUSETrump Orders Childhood Vaccine Schedule Spacinglast weekENERGYMichigan Court Rejects Enbridge Line 5 Permit Under Great Lakes2 weeks agoWHITE HOUSETrump Order Splits MMR Vaccine—Pharma Faces Demand Shift2 weeks agoDEFENSEPentagon Awards Space-Based Target Tracking Contracts2 weeks agoDEFENSETrump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gains2 weeks agoTECHTrump Administration Adds 6 Chipmakers to U.S. Portfolio2 weeks agoWHITE HOUSEWhite House Drafts Vaccine-Autism Order—Pharma Faces Uncertainty2 weeks ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Healthcare & FDA

FDA Clears Robotic Blood Draw—Phlebotomy Shortage Eases

Aletta device addresses labor crunch; benefits hospital operators and device makers.

Image: Money Racket
By at Money Racket · Aug 25, 2026

The FDA authorized Aletta on August 19, 2026, the first standalone robotic blood draw device that operates with minimal hands-on oversight. One phlebotomist can supervise up to three devices simultaneously, directly addressing the chronic U.S. phlebotomy shortage.

Robotic blood draw cuts labor costs for labs and hospitals—but threatens independent phlebotomy staffing and entry-level job growth.

The primary beneficiary is the device maker—likely a private company or a subsidiary of a larger medtech firm. However, hospital operators and outpatient lab networks gain immediate operational relief. Quest Diagnostics (DGX) and LabCorp (LH) benefit from reduced labor costs and faster throughput, improving margins on routine blood work. Fresenius Medical Care (FMS) and dialysis operators also benefit, as blood draws are frequent in their workflows. Larger hospital systems like HCA Healthcare HCA and Tenet Healthcare THC can deploy Aletta to reduce staffing pressure and redirect phlebotomists to more complex procedures.

At risk are independent phlebotomy services and staffing agencies that rely on high-volume routine draws. Automation reduces demand for entry-level phlebotomists, pressuring wage growth and headcount at staffing firms like Aya Healthcare (verify ticker) and regional lab operators.

Watch for adoption rates in Q4 2026 and Q1 2027. If hospitals rapidly deploy Aletta, expect margin expansion at DGX and LH. If reimbursement doesn't improve or regulatory hurdles emerge, adoption will stall.

Source: original report ↗

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $40/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://moneyracket.com/article/fda-authorizes-robotic-blood-draw-device-aletta/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo →